Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$GANX

Gain Therapeutics, Inc. Common Stock

XNAS

$1.69+0.60%+$0.0100Prev $1.68LIVE Full chart Live alerts
No recent price bars, the chart lights up when GANX starts printing.

As of the latest tick, GANX is trading at $1.69, up 0.60% versus the previous close of $1.68.

Key Stats

Price & performance
Price
$1.69
Change today
+0.60%
Previous close
$1.68
52-week range
$1.41 – $4.34
Valuation & dividend
Market cap
$72M
Ownership & volume
Shares outstanding
42.7M
SEC 10-Q · May 11, 2026
Institutional own.
20.55%
Avg daily volume
911K
Next earnings
Aug 11 · in 27d
Classification
Exchange
XNAS

Why is $GANX up today?

3 alerts today31.8x RVOL

GANX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on GANX today, peaking at 31.8x its normal volume.

Likely catalystClinical / FDA update, from the latest SEC filing. Read it →
Why is $GANX moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy4 analysts
Avg target $7.20(+326% upside)
Range $5 – $8
4 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

2 open-market buys0 buys, 0 sells last 3 months (0/0 over 12 months)
Show 2 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Mack Gene
Officer
Bought (open market)+14K
0.03% of company
n/a14K$15K
at $1.01
Aug 9, 24
Islam Khalid
Officer
Bought (open market)+50K
0.1% of company
n/a50K$50K
at $1.00
Aug 9, 24

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Active offering

Recent share offering on file, active dilution risk. If $GANX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings. Offering terms are read straight from the filing text where available. Form type signals dilution capacity, not an exact share count. Not investment advice.

$GANX Sentiment

Bullish
Bearish80Bullish
📰 News: 4 bull · 0 bearToday: +0.6%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$GANX Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 4h ago -2.0% vs EMA
$GANX near 200 EMA: -1.99% from 200 EMA at 1:35 PM ET
at $1.65
Alert· 4h ago +1.85%
$GANX moved +1.85% in 1 min (Level 1) at 1:35 PM ET
at $1.66
Alert· 4h ago 28.7× RVOL
GANX hit 28.691x RVOL at 1:35 PM ET
at $1.65
Alert· 5h ago 31.8× RVOL
GANX hit 31.788x RVOL at 12:32 PM ET
at $1.63
Alert· 1d ago 20.4× RVOL
GANX hit 20.377x RVOL at 2:04 PM ET
at $1.77
Alert· 1d ago 11.0× RVOL
GANX hit 10.960x RVOL at 12:37 PM ET
at $1.83
News· SEC EDGAR· 16d ago
Gain Therapeutics, Inc. filed an 8-K: Other Material Event
News· SEC EDGAR· 20d ago
Gain Therapeutics, Inc. filed an 8-K: Shareholder Vote
News· GlobeNewswire Inc.· 35d ago Bullish
Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
News· SEC EDGAR· 50d ago
Gain Therapeutics, Inc. filed an 8-K: Other Material Event
News· SEC EDGAR· 65d ago
Gain Therapeutics, Inc. filed a Quarterly report (10-Q)
News· GlobeNewswire Inc.· 118d ago Bullish
Gain Therapeutics to Present at the 38th Annual ROTH Conference
News· GlobeNewswire Inc.· 272d ago Bullish
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
News· GlobeNewswire Inc.· 653d ago Bullish
Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson’s Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

Free alerts

Get free $GANX alerts the moment volume spikes

Our scanner flagged $GANX 5 times in the last 30 days. Create a free account to track $GANX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

GANX stock FAQ

Why is $GANX up today?

GANX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on GANX today, peaking at 31.8x its normal volume.

What is the GANX stock price today?

GANX last traded at $1.69, up 0.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live GANX alerts?

The GANX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GANX 5 times in the last 30 days.

What exchange is GANX on?

GANX (Gain Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $72M.

Is GANX good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GANX for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.